These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 27038346)

  • 1. Errors in meta-analysis on prevalence of nonalcoholic fatty liver disease.
    Roerecke M; Rehm J; Neuman M
    Hepatology; 2016 Oct; 64(4):1389-90. PubMed ID: 27038346
    [No Abstract]   [Full Text] [Related]  

  • 2. The relationship between insulin resistance, metabolic syndrome and nonalcoholic fatty liver disease in non-obese non-diabetic Turkish individuals: A pilot study.
    Erkan G; Sayın I; Polat FB; Çorakçı A; Ataç GK; Değertekin H
    Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():63-8. PubMed ID: 25910371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of nonalcoholic fatty liver disease in the middle eastern area: What is the exact estimation?
    Naderian M; Ebrahimi H; Sohrabpour AA
    Hepatology; 2016 Oct; 64(4):1390-1. PubMed ID: 27045003
    [No Abstract]   [Full Text] [Related]  

  • 4. Nonalcoholic fatty liver disease: epidemiology, pathogenesis and therapeutic implications.
    Andronescu CI; Purcarea MR; Babes PA
    J Med Life; 2018; 11(1):20-23. PubMed ID: 29696060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevalence of nonalcoholic fatty liver disease and metabolic abnormalities in 387 obese children and adolescents in Beijing, China].
    Zhou X; Hou DQ; Duan JL; Sun Y; Cheng H; Zhao XY; Liu JT; Yang P; Shan XY; Mi J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 May; 34(5):446-50. PubMed ID: 24016432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commentary: Nonalcoholic or metabolic dysfunction-associated fatty liver disease? The epidemic of the 21st century in search of the most appropriate name.
    Polyzos SA; Kang ES; Tsochatzis EA; Kechagias S; Ekstedt M; Xanthakos S; Lonardo A; Mantovani A; Tilg H; Côté I; Grefhorst A; Greene MW; Araujo-Vilar D; Alisi A; Casanueva F; Mantzoros CS
    Metabolism; 2020 Dec; 113():154413. PubMed ID: 33164861
    [No Abstract]   [Full Text] [Related]  

  • 7. Global epidemiology of nonalcoholic fatty liver disease: Meta-analytic assessment of prevalence, incidence, and outcomes.
    Lonardo A; Byrne CD; Caldwell SH; Cortez-Pinto H; Targher G
    Hepatology; 2016 Oct; 64(4):1388-9. PubMed ID: 27038241
    [No Abstract]   [Full Text] [Related]  

  • 8. Nonalcoholic fatty liver disease in Asia: emerging perspectives.
    Seto WK; Yuen MF
    J Gastroenterol; 2017 Feb; 52(2):164-174. PubMed ID: 27637587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.
    Alkassabany YM; Farghaly AG; El-Ghitany EM
    Arab J Gastroenterol; 2014 Jun; 15(2):76-81. PubMed ID: 25097051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence of nonalcoholic fatty liver disease in Asia].
    Zhang W; Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2013 Nov; 21(11):801-4. PubMed ID: 24516923
    [No Abstract]   [Full Text] [Related]  

  • 11. Copper deficiency and nonalcoholic fatty liver disease: The chicken or the egg?
    Ito H
    Clin Nutr; 2021 Aug; 40(8):4914. PubMed ID: 34358837
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.
    Younossi ZM; Henry L; Bush H; Mishra A
    Clin Liver Dis; 2018 Feb; 22(1):1-10. PubMed ID: 29128049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between non-alcoholic fatty liver disease, metabolic syndrome and insulin resistance in Korean adults: A cross-sectional study.
    Kim JY; Lee C; Oh M; Im JA; Lee JW; Chu SH; Lee H; Jeon JY
    Clin Chim Acta; 2016 Jul; 458():12-7. PubMed ID: 27020118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Nonalcoholic Fatty Liver Disease on Cardiovascular Manifestations and Outcomes.
    Kovalic AJ; Satapathy SK
    Clin Liver Dis; 2018 Feb; 22(1):141-174. PubMed ID: 29128054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery.
    Seki Y; Kakizaki S; Horiguchi N; Hashizume H; Tojima H; Yamazaki Y; Sato K; Kusano M; Yamada M; Kasama K
    J Gastroenterol; 2016 Mar; 51(3):281-9. PubMed ID: 26314837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-alcoholic fatty liver disease and hypertension: coprevalent or correlated?
    Oikonomou D; Georgiopoulos G; Katsi V; Kourek C; Tsioufis C; Alexopoulou A; Koutli E; Tousoulis D
    Eur J Gastroenterol Hepatol; 2018 Sep; 30(9):979-985. PubMed ID: 30048367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age at menarche is associated with the prevalence of non-alcoholic fatty liver disease later in life.
    Lu J; Zhang J; Du R; Wang T; Xu M; Xu Y; Wang W; Bi Y; Li D; Chen Y; Ning G
    J Diabetes; 2017 Jan; 9(1):53-60. PubMed ID: 26800495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The globalization of nonalcoholic fatty liver disease: Prevalence and impact on world health.
    Rinella M; Charlton M
    Hepatology; 2016 Jul; 64(1):19-22. PubMed ID: 26926530
    [No Abstract]   [Full Text] [Related]  

  • 19. Nonalcoholic Fatty Liver Disease.
    Sweet PH; Khoo T; Nguyen S
    Prim Care; 2017 Dec; 44(4):599-607. PubMed ID: 29132522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship between ideal cardiovascular behaviors/factors and the prevalence of nonalcoholic fatty liver disease].
    Xing A; Ji C; Shi J; Du X; Huang Z; Lin L; Xiong H; Wu S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Jan; 36(1):40-4. PubMed ID: 25876863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.